Beckman Coulter Life Sciences Features Genomic, Cellular Solutions at SLAS2013

INDIANAPOLIS, IND. –– Bringing together genomic and cellular sample preparation with integrated solutions to highlight their Automation with a Human Touch theme, Beckman Coulter Life Sciences will offer two workshops and present workstations addressing a range of applications in booth 921 when SLAS2013 convenes in Orlando, Fla., from January 12-16. Workshops offered by the company [...]

Illumina Announces Sequencing Technology Innovations

SAN DIEGO -- Illumina (NASDAQ: ILMN) today announced a series of product and technology innovations for its powerful sequencing ecosystem – from sample preparation to system enhancements to data analysis –– that will enable the next breakthroughs in understanding the genome. “Illumina has consistently led the market in conceptualizing, developing, and executing on industry-changing sequencing [...]

HighRes Biosolutions delivers state-of-the-art ultra-high-throughput drug screening system to Pivot Park Screening Centre, The Netherlands

Pivot Park Screening Centre (Oss, Netherlands) has recently taken delivery of a flexible laboratory automation system from HighRes Biosolutions, forming the core of its newly implemented ultra-high-throughput screening (uHTS) facility. Pivot Park Screening Centre will use the uHTS system to perform biochemical and cell-based screening assays to support research programs across public and private partnerships. [...]

Danaher CEO Comments on Outlook

Washington, D.C.,- Danaher Corporation (NYSE:DHR) announced that its President and Chief Executive Officer, H. Lawrence Culp, Jr., will comment tomorrow on the Company's performance in a presentation at the J.P. Morgan Healthcare Conference in San Francisco, CA. Mr. Culp will communicate that the Company's fourth quarter 2012 diluted net earnings per share is anticipated to [...]

IntelligentMDx Enters into an Agreement with QIAGEN to Develop and Manufacture Molecular Tests

CAMBRIDGE, MASSACHUSETTS –— IntelligentMDx (privately held) announced today that it has entered into a multi-year development and license agreement with QIAGEN (NASDAQ: QGEN, Frankfurt Prime Standard: QIA) to design, develop and manufacture several undisclosed CE-marked and FDA cleared diagnostic tests for use on QIAGEN's flagship QIAsymphony RGQ automated platform. Financial terms have not been disclosed. [...]

Rolland Carlson, Ph.D. named CEO of Asuragen

Austin, Texas – Asuragen Inc., a leading molecular diagnostic company, announced today that Rollie Carlson, previously the President and Chief Operating Officer of the Company, has been appointed President and CEO. Matt Winkler, the founder and prior CEO of Asuragen, will retain the role of Chairman of the Board and Chief Scientific Officer. "I had [...]

Labcyte and FIMM Announce a Collaboration Enabling “Real-Time” Science to Advance Personalized Medicine in Cancer Treatments

SUNNYVALE, Calif. & HELSINKI -- Labcyte Inc. and the Institute for Molecular Medicine Finland (FIMM) are collaborating to further the development of personalized medicine in cancer treatment. Labcyte acoustic liquid handling technology has already revolutionized small-molecule research. Now, FIMM, a European leader in advanced research for new cancer therapies, will apply the technology extensively in [...]

Artel simplifies the verification of low-volume DMSO dispenses

Westbrook, ME – Artel is launching the first in a new line of 100% DMSO-based Sample Solutions for use with the MVS® Multichannel Verification System. These will provide users with the ability to measure the accuracy and precision of volumes of DMSO dispensed into microwell plates. The first in the new line of DMSO solutions [...]

Dako Enters Collaboration with Eli Lilly and Company for Development of Companion Diagnostics

Dako, an Agilent Technologies company, announced today it has entered into a master framework agreement with Eli Lilly and Company for the development of companion diagnostic tests to identify patients who may be more likely to benefit from an investigational oncology medicine currently under development by Lilly. The agreement constitutes a framework for collaboration between [...]

Shimadzu’s New HS-20 Gas Chromatography Headspace Sampler Achieves Accurate Analysis of a Wide Range of Volatile Compounds

—Enables Simultaneous Analysis of Low to High Boiling Point Compounds— Shimadzu Corporation has launched the HS-20 gas chromatography headspace sampler for accurate analysis of a wide range of volatile compounds with low to high boiling points. Headspace samplers heat liquid or solid samples sealed in a container to a certain temperature, and introduce the volatile [...]

Access IBO on Knowledge Center